http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2419768-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b51d317764e2f4f1bbcb355b274c8b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C307-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C307-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-36
filingDate 2001-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b66254af634a66aed862ae722e9a4870
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7f86481229402af3494fedcf196c614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7be269e609599ae18bb0d1882b781a
publicationDate 2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2419768-A1
titleOfInvention Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same
abstract New sulfamide compounds and methods of forming those compounds are provided. The inventive methods comprise subjecting a template opened-ring sulfamide compound to a ring-closing metathesis reaction in the presence of a Grubbs catalyst to yield a heterocyclic sulfamide. Advantageously, the template structures can be provided with a wide array of functional groups (e.g., substituted and unsubstituted amino acid side chains, peptides) chosen to provide particular properties to the compound. The preferred heterocyclic sulfamides are represented by a formula selected from the group consisting of formulae (I), (II), (III), and (IV).
priorityDate 2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406948316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693

Total number of triples: 36.